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PRIMARY IMMUNOBLASTIC B-CELL LYMPHOMA OF THE STERNUM 
Peter L. Faries, MD, a Marcus D'Ayala, MD, a and Gil Hauer Santos, MD, b Bronx, N.Y. 
A 38-year-old man was referred to us with a painful 
sternal mass. On examination a firm, fixed, tender 3 × 3 
cm sternal mass was present at the level of the third rib. 
Roentgenographic and computed tomographic studies of 
the chest demonstrated a 2.5 × 3 × 3 cm lytic mass 
originating in the right side of the sternum at the level of 
the third rib (Fig. 1). No extension into the mediastinum 
and no mediastinal or hilar adenopathy were present. The 
lung fields were clear and the large airways were without 
compromise. Computed tomographic scans of the head, 
abdomen, and pelvis, a radionuclide bone scan, and 
bronchoscopic examination demonstrated no evidence of 
malignant disease at other sites. 
At operation an incisional biopsy with frozen section 
demonstrated large cell lymphoma, and the patient un- 
derwent surgical resection of the mass for palliation of his 
pain and tumor debulking. The lower end of the manu- 
brium and the sternum were resected from the first to the 
fourth intercostal spaces with the second and third costal 
cartilages bilaterally. The tumor was excised without 
dissection of the mediastinum. Prosthetic reconstruction 
was unnecessary. The pectoralis muscles and overlying 
skin were mobilized bilaterally and used to repair the soft 
tissue defect. The patient was extubated in the operating 
room. He had an uneventful recovery and was discharged 
from the hospital on the sixth postoperative day. At the 
time of discharge he had no difficulty in mobilizing the 
chest wall for gas exchange satisfactory for usual activity. 
Pathologic examination of the specimen demonstrated 
a soft pink-tan lesion originating in the sternum, replacing 
the trabecular bone and thinning the cortical bone. The 
tumor did not extend to the mediastinum. Microscopic 
evaluation demonstrated sheets of malignant, highly ple- 
omorphic lymphocytes within the sternal mass (Fig. 2). 
Extensive necrosis and a high mitotic rate were present, 
and plasmacytoid and polymorphous immunoblastic fea- 
tures of lymphoma were seen. Immunohistochemical 
analysis was positive for lymphocyte (LCA) and B-cell 
(L26) markers and negative for T-cell (UCHL1) and 
neuroendocrine (S100, chromogranin) markers, confirm- 
ing the diagnosis of a non-Hodgkin's immunoblastic B-cell 
lymphoma originating in the sternum. The patient re- 
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Fig. 1. Computed tomographic scan of sternal lym- 
phoma. Lytic destruction of the right sternum is evident 
(arrow). No calcification or invasion of the mediastinum is 
present. 
ceived six cycles of cyclophosphamide, doxorubicin, vin- 
cristine, and prednisone and is well with no evidence of 
active disease 2 years after the operation. 
The management of sternal tumors may be complex 
and is typically directed by the histologic nature of the 
tumor, its location, and the extent of involvement of the 
sternum and adjoining structures. The majority of sternal 
tumors are malignant. Primary solid and small cell tumors, 
as well as metastatic lesions, have been reported. 1 
Both Hodgkin's disease and non-Hodgkin's lymphoma 
involving the sternum and chest wall have been described. 
Frequently the malignancy originates within lymph nodes 
of the mediastinum or internal thoracic hain and invades 
the chest wall through direct extension. Mediastinal ade- 
nopathy occurs frequently in Hodgkin's disease but is 
unusual in non-Hodgkin's lymphoma, in which endobron- 
chial and diffuse interstitial involvement occur. Isolated 
chest wall masses are distinctly uncommon and are usually 
a manifestation of large cell non-Hodgkin's lymphoma. 
One case of localized Hodgkin's disease that was detected 
as a sternal tumor and required total sternectomy plus 
reconstruction with a Marlex mesh prosthesis (Bard Im- 
plants, Billerica, Mass.) has been reported. 2 A case of 
non-Hodgkin's lymphoma of lymphoid progenitor ceil 
origin appearing as a lytic sternal lesion has also been 
described. 3 That patient was treated with radiation and 
chemotherapy but died 7 months after the initial diagno- 
sis. Six cases of high-grade malignant lymphoma of the 
sternum have also been reported. Two of the patients 
were treated with sternectomy, three with radiation, and 
one with chemotherapy, with an overall 10-year survival of 
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Fig. 2. Histologic section of the sternal lymphoma. Malignant, highly pleomorphic lymphocytes (black 
arrows) are seen invading the trabecular bone (open arrow) of the sternum. A high miotic rate and 
immunoblastic features are present (hematoxylin and eosin stain; original magnification ×100). 
83%. 1 Non-Hodgkin's lymphoma of the anterior medias- 
tinum with evidence of B-cell origin has also been seen, 4
but no case of B-cell immunoblastic non-Hodgkin's lym- 
phoma originating in the sternum has been reported 
previously. 
Resection of sternal tumors with adequate surgical 
margins of 4 cm may result in substantial bony and soft 
tissue defects. Loss of the upper sternal body and the 
costal cartilages, as in this case, produces a defect that is
not physiologically significant. More extensive resections 
including the entire sternal body or manubrium with the 
adjacent ribs and clavicles produce more severe deficits. 
Reconstruction is therefore necessary to avoid prolonged 
ventilatory support. 1 Reconstruction after sternal resec- 
tion can be performed with a variety of materials. Skin 
defects are frequently small and are most often covered 
primarily by advancing skin flaps. Larger defects may 
require split-thickness kin grafting or closure as part of a 
myocutaneous tissue flap. Underlying soft tissue defects 
may be closed by advancing pectoralis muscle flaps, by 
transposition of a free tissue graft, or by an omental flap. 
Prosthetic materials including polytetrafluoroethylene, 
methyl methacrylate, polypropylene, polyethylene, and 
steel mesh have all been used successfully in reconstruct- 
ing sternal defects,  
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